Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic SWOT Analysis Review
GlobalData
February 6, 2012 35 Pages - SKU: GBDT6797943
|
|
Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic SWOT Analysis Review
Summary
Questcor Pharmaceuticals, Inc. (Questcor Pharma) is a publicly held bio pharmaceutical company. It is specialized in the provision of prescription drugs for treating rare central nervous system and inflammatory disorders. The product portfolio of the company include H.P. Acthar gel (repository corticotropin hormone) a naturally-derived formulation of adrenocorticotropic hormone for use in various disorders having an inflammatory component; and Doral used for the treatment of insomnia.
Questcor Pharmaceuticals, Inc. Key Recent Developments
Oct 27, 2011 Questcor Teams With Child Neurology Foundation To Continue Funding Infantile Spasms Scientific Research
Oct 25, 2011 Questcor Pharmaceuticals Reports Revenue Of $59.8m In Q3 2011
Jul 26, 2011 Questcor Reports Net Sales Of $46m For Q2 2011
Apr 26, 2011 Questcor Pharmaceuticals Reports Net Income Of $11.2m For Q1 2011
This comprehensive SWOT profile of Questcor Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
|
Section 1 - About the Company - Questcor Pharmaceuticals, Inc. - Key Facts
- Questcor Pharmaceuticals, Inc. - Key Employees
- Questcor Pharmaceuticals, Inc. - Key Employee Biographies
- Questcor Pharmaceuticals, Inc. - Major Products and Services
- Questcor Pharmaceuticals, Inc. - History
- Questcor Pharmaceuticals, Inc. - Company Statement
- Questcor Pharmaceuticals, Inc. - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 - Company Analysis
- Questcor Pharmaceuticals, Inc. - Business Description
- Questcor Pharmaceuticals, Inc. - Corporate Strategy
- Questcor Pharmaceuticals, Inc. - SWOT Analysis
- SWOT Analysis - Overview
- Questcor Pharmaceuticals, Inc. - Strengths
- Strength - Product Portfolio
- Strength - Partnerships Agreements
- Strength - Sound Profitability Indicators
- Strength - Healthy Liquidity Position
- Questcor Pharmaceuticals, Inc. - Weaknesses
- Weakness - Dependence on Acthar
- Questcor Pharmaceuticals, Inc. - Opportunities
- Opportunity - Sales Force Expansion
- Opportunity - Focus on Innovation
- Questcor Pharmaceuticals, Inc. - Threats
- Threat - Uncertain R&D Outcomes
- Threat - Competitive Landscape
- Threat - Government Regulations
- Questcor Pharmaceuticals, Inc. - Key Competitors
- Section 3 - Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 - Company’s Lifesciences Financial Deals and Alliances
- Questcor Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
- Questcor Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
- Questcor Pharmaceuticals, Inc., Recent Deals Summary
- Section 5 - Company’s Recent Developments
- Questcor Pharmaceuticals, Inc., Recent Developments
- Oct 27, 2011: Questcor Teams With Child Neurology Foundation To Continue Funding Infantile Spasms Scientific Research
- Oct 27, 2011: Questcor Teams With Child Neurology Foundation To Continue Funding Infantile Spasms Scientific Research
- Oct 25, 2011: Questcor Pharmaceuticals Reports Revenue Of $59.8m In Q3 2011
- Jul 26, 2011: Questcor Reports Net Sales Of $46m For Q2 2011
- Apr 26, 2011: Questcor Pharmaceuticals Reports Net Income Of $11.2m For Q1 2011
- Feb 23, 2011: Questcor Reports Net Income Of $6.4m For Q4 2010
- Feb 16, 2011: Questcor Pharmaceuticals To Be Added To S&P SmallCap 600 Index
- Jan 10, 2011: Questcor Pharmaceuticals Appoints Michael Mulroy As CFO
- Section 6 - Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Questcor Pharmaceuticals, Inc., Key Facts
- Questcor Pharmaceuticals, Inc., Key Employees
- Questcor Pharmaceuticals, Inc., Key Employee Biographies
- Questcor Pharmaceuticals, Inc., Major Products and Services
- Questcor Pharmaceuticals, Inc., History
- Questcor Pharmaceuticals, Inc., Other Locations
- Questcor Pharmaceuticals, Inc., Key Competitors
- Questcor Pharmaceuticals, Inc., Ratios based on current share price
- Questcor Pharmaceuticals, Inc., Annual Ratios
- Questcor Pharmaceuticals, Inc., Interim Ratios
- Questcor Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
- Questcor Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
- Questcor Pharmaceuticals, Inc., Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Questcor Pharmaceuticals, Inc., Performance Chart (2006 - 2010)
- Questcor Pharmaceuticals, Inc., Ratio Charts
- Questcor Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
- Questcor Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
Share this report
Other tasks Related Markets Pharmaceuticals Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
